Trulieve Cannabis Corp.
corporate_fare Company Profile
Trulieve Cannabis Corp. (NYSE:TRLV) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 8 items for TRLV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for TRLV spans 10-Q, 8-K, DEF 14A, 144.
Recent high-impact activity:
- Trulieve 10-Q: Q3 Swings to $869K Net Income, $326.7M Cash, $403.3M Harvest Charge
- Trulieve Posts $230M Q3 Revenue, 64% Margin, $89M Adjusted EBITDA
- Trulieve Q2 2026: A $403M Deconsolidation Loss Obscures Resilient Medical-Only Operations
- Trulieve Q2: $271M Revenue, $98M Adj. EBITDA, Harvest Deconsolidation Drives $406M Net Loss
- Trulieve Cannabis Corp. Finalizes Plan to Re-domicile to Delaware, Sets Shareholder Vote
Financial Snapshot
Short Interest & Short Volume
3.37 days to coverFINRA reported short interest of 3,841,922 shares in TRLV as of the October 30, 2026 settlement, a 47.1% decrease from the prior period — about 3.4 days to cover at its recent average daily volume. On November 20, 2026, 39.3% of TRLV volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.